| argenx to Present Phase 3 ALKIVIA Results in Autoimmune Myositis as a Late-Breaking Oral Presentation at ACR Convergence 2026 |
Globe Newswire |
10/19 |
08:00 |
| Calidi Biotherapeutics to Present New CLD-401 Data and In Situ TCE Platform Advances at the ESMO Congress 2026 |
Globe Newswire |
10/19 |
08:00 |
| GuideAI Health Enters Clinical Study and Software Pilot Agreement with Boone Heart Institute |
Globe Newswire |
10/19 |
08:00 |
| Micron to Host Technology Webinar on Oct. 21 |
Globe Newswire |
10/19 |
08:00 |
| Nextiva Selects Intrado NG Nexus™ to Advance NG9-1-1 Compliance Readiness |
Globe Newswire |
10/19 |
08:00 |
| Aqua Finance Names Michelle Gill as Chief Executive Officer |
Globe Newswire |
10/19 |
08:00 |
| ASML reports transactions under its current share buyback program |
Globe Newswire |
10/19 |
08:00 |
| SpyGlass Pharma Announces Positive 4-Year Data From First-in-Human Trial of Its Innovative BIM-IOL System |
Globe Newswire |
10/19 |
08:00 |
| Resmed Launches AirTouch™ F40 Full Face Fabric CPAP Mask in the U.S. |
Globe Newswire |
10/19 |
08:00 |
| OFA Group Enters Public-Private Sounding Survey for 3.71-Hectare Naarai Port Green Space, Expanding Its Development Footprint in Choshi |
Globe Newswire |
10/19 |
08:00 |
| Baird Medical Announces Regulatory Milestones in Vietnam and Egypt, Expanding International Reach of Microwave Ablation Technology |
Globe Newswire |
10/19 |
08:00 |
| UroGen Announces FDA Acceptance of the New Drug Application for UGN-103, an Investigational Treatment for Adults with Recurrent LG-IR-NMIBC |
Globe Newswire |
10/19 |
08:00 |
| Medera's Novoheart Technology Powers Advanced Human Cardiac Disease Modeling at Singapore's New CIPHER Research Centre |
Globe Newswire |
10/19 |
08:00 |
| Nyxoah Announces Preliminary Results for the Third Quarter of 2026 and Adjusts Revenue Guidance for 2026 |
Globe Newswire |
10/19 |
08:00 |
| Vaxart Appoints Retired Vice Admiral Raquel C. Bono, M.D., to Board of Directors |
Globe Newswire |
10/19 |
08:00 |
| COSCIENS ANNOUNCES NEW CORPORATE PRESENTATION AND PROVIDES UPDATE ON CONVERTIBLE DEBENTURE OFFERING |
Globe Newswire |
10/19 |
08:00 |
| DarkIris Inc. Announces Share Consolidation |
Globe Newswire |
10/19 |
08:00 |
| TransUnion’s “Bring Clarity to Chaos” Campaign Wins 2026 MediaPost OMMA Award |
Globe Newswire |
10/19 |
08:00 |
| 3 E Network Signs Core 9 MVA Power Distribution Agreement for Mikkeli AI Compute Center in Finland |
Globe Newswire |
10/19 |
07:50 |
| Ritedose Partners with Newberry College to Launch Leadership Development Program |
Globe Newswire |
10/19 |
07:43 |
| Rekor Systems Takes Legal Action Against Former Director Following Extensive Investigation into Alleged Breaches of Fiduciary Duty in Connection with a December 2025 Financing with a Hedge Fund |
Globe Newswire |
10/19 |
07:30 |
| Paratek Pharmaceuticals to Present New Data on NUZYRA® (omadacycline) at IDWeek 2026 |
Globe Newswire |
10/19 |
07:30 |
| Chase Bell and Lira Bring Their “Do Me” Collaboration to Hollywood in a Sold-Out Performance at East West Studios |
Globe Newswire |
10/19 |
07:30 |
| BrainsWay Announces Strategic Collaboration with Inland Psychiatry Medical Group |
Globe Newswire |
10/19 |
07:30 |
| Biogen to Present New Data Across Nephrology Portfolio, Including Long-term EMPAVELI® (pegcetacoplan) Phase 3 Results, at American Society of Nephrology (ASN) Kidney Week |
Globe Newswire |
10/19 |
07:30 |
